VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-01210 Package ID: USCOURTS-cofc-1_22-vv-01210 Petitioner: Mary Trepanier Filed: 2022-09-02 Decided: 2025-03-31 Vaccine: influenza Vaccination date: 2020-10-09 Condition: transverse myelitis Outcome: dismissed Award amount USD: AI-assisted case summary: On September 2, 2022, Mary Trepanier filed a petition alleging that she developed transverse myelitis after receiving an influenza vaccine on October 9, 2020. The public dismissal decision states that she presented about three weeks later with numbness, but it does not set out the diagnostic testing, treatment course, steroid response, or residual medical history in detail. Respondent filed a Rule 4(c) report recommending denial of entitlement. After reviewing the record, Ms. Trepanier indicated that she could not obtain an expert report to support vaccine causation and that she no longer wished to pursue the claim. On March 31, 2025, Chief Special Master Brian H. Corcoran granted her motion for a decision dismissing the petition. The dismissal was with prejudice for insufficient proof. A later attorneys' fees decision did not represent vaccine-injury compensation. Theory of causation field: Influenza vaccine October 9, 2020 allegedly causing transverse myelitis; adult, exact age not stated; public text says numbness presentation about three weeks later. DISMISSED with prejudice on petitioner's motion after respondent recommended denial and petitioner could not obtain expert support. No injury-compensation award. Chief SM Brian H. Corcoran; petition September 2, 2022; dismissal March 31, 2025. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_22-vv-01210-0 Date issued/filed: 2025-04-28 Pages: 3 Docket text: PUBLIC DECISION (Originally filed: 03/31/2025) regarding 46 DECISION of Special Master. Signed by Chief Special Master Brian H. Corcoran. (mva) Service on parties made. -------------------------------------------------------------------------------- Case 1:22-vv-01210-UNJ Document 47 Filed 04/28/25 Page 1 of 3 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 22-1210V * * * * * * * * * * * * * * * * * * * * * * * * * * MARY TREPANIER, * Chief Special Master Corcoran * Petitioner, * Filed: March 31, 2025 * v. * * SECRETARY OF HEALTH AND * HUMAN SERVICES * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * Ronald C. Homer, Conway, Homer, P.C., Boston, MA, for Petitioner. James Vincent Lopez, U.S. Dep’t of Justice, Washington, DC, for Petitioner. DECISION DISMISSING PETITION1 On September 2, 2022, Mary Trepanier filed a petition seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”).2 Petitioner alleged that she suffered transverse myelitis as a result of an influenza vaccine administered on October 9, 2020. See generally Amended Petition (ECF No. 30). On August 12, 2024, Respondent filed his Rule 4(c) Report recommending denial of compensation in this matter. See Report (ECF No. 41). I subsequently held a status conference, and at that time directed Petitioner to file an expert report. See Scheduling Order, dated Aug. 28, 2024. 1 Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) [hereinafter “Vaccine Act” or “the Act”]. Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Case 1:22-vv-01210-UNJ Document 47 Filed 04/28/25 Page 2 of 3 By February 2025, Petitioner had still not filed an expert report, so I held a status conference to discuss her progress. Petitioner explained that she had not been able to procure an expert report, so I instructed her to either dismiss the claim pursuant to Vaccine Rule 21 or request a status conference explaining how she intends to move forward. See Scheduling Order, dated Feb. 7, 2025. Petitioner has now filed a motion for a decision dismissing the claim. See Motion, dated Mar. 31, 2025 (ECF No. 45). Petitioner explains that she has opted to not proceed with her claim. Mot. at 2. Petitioner has been advised that a decision dismissing the petition will result in a judgment against her, and that such a judgment will end all her rights in the Vaccine Program with regard to this specific claim relating to her October 9, 2020 vaccination. Id. Vaccine Rule 21(b) provides that I may dismiss a petition or any claim therein at the request of Petitioner, on terms that I consider proper, by issuance of a decision pursuant to Section 12(d)(3) of the Vaccine Act. Under this rule, a petitioner may request a decision dismissing a petition, even after preparation of Respondent’s Rule 4(c) Report. In such a case, the decision will result in a judgment, although the dismissal will be with prejudice (unless otherwise indicated). Rule 21(b)(1) and (2). Here, I find such a decision appropriate. To be entitled to compensation under the Vaccine Act, a petitioner must demonstrate that he or she 1) suffered a “Table Injury”—i.e., an injury falling within the Vaccine Injury Table— corresponding to his vaccination, or 2) that she suffered an injury that was actually caused by a vaccine. See § 13(a)(1)(A) and 11(c)(1). Petitioner has affirmatively represented that she prefers to no longer proceed with her claim, however, and has not otherwise offered evidence sufficient to support the claim. Examination of the record does not disclose sufficient evidence to establish that Petitioner suffered a “Table Injury.” Further, the record does not contain a medical expert’s opinion or any other persuasive evidence indicating that Petitioner’s alleged injury was vaccine- caused. Under the Vaccine Act, a petitioner may not be awarded compensation based on the petitioner’s claims alone. Rather, the petition must be supported by either the medical records or by a medical opinion. Section 13(a)(1). In this case, the record does not contain medical records or a medical opinion sufficient to demonstrate that Petitioner was injured by a vaccine. Accordingly, I hereby DISMISS the Petition with prejudice. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court SHALL ENTER JUDGMENT in accordance with the terms of this Decision.3 3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment if (jointly or separately) they file notices renouncing their right to seek review. 2 Case 1:22-vv-01210-UNJ Document 47 Filed 04/28/25 Page 3 of 3 IT IS SO ORDERED. /s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_22-vv-01210-cl-extra-11248130 Date issued/filed: 2026-01-29 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10781507 -------------------------------------------------------------------------------- &255(&7(' In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 22-1210V ************************* * MARY TREPANIER, * Chief Special Master Corcoran * Petitioner, * Filed: December 29, 2025 * v. * * SECRETARY OF HEALTH AND * HUMAN SERVICES * * Respondent. * * ************************* Ronald C. Homer, Conway, Homer, P.C., Boston, MA, for Petitioner. James Vincent Lopez, U.S. Dep’t of Justice, Washington, DC, for Petitioner. DECISION GRANTING IN PART FINAL AWARD OF ATTORNEY’S FEES AND COSTS 1 On September 2, 2022, Mary Trepanier filed a petition seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”). 2 Petitioner alleged that she suffered transverse myelitis as a result of an influenza vaccine administered on October 9, 2020. See generally Amended Petition (ECF No. 30). Petitioner was unable to obtain expert support for her claim, and ultimately requested dismissal of the matter, which occurred last spring. Decision Dismissing Case, dated Mar. 31, 2025, (ECF No. 46) (“Decision”). 1 Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) [hereinafter “Vaccine Act” or “the Act”]. Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Petitioner has now filed a motion for a final award of attorney’s fees and costs. Motion, dated Oct. 16, 2025 (ECF No. 50) (“Mot.”). This is Petitioner’s sole such request. Petitioner requests $55,479.89, reflecting $53,602.60 in attorney’s fees, plus $1,877.29 in costs, for the work performed by attorneys at the law firm of Conway, Homer, P.C. Mot. at 1–2. The requested costs include Petitioner’s unreimbursed litigation costs, which are discussed in greater detail below. Respondent reacted to the present fees request on July 8, 2025. See Response, dated Oct. 20, 2025 (ECF No. 28) (“Resp.”). Respondent agrees that Petitioner has satisfied the statutory requirement for a fees award, but otherwise defers the calculation of the amount to be awarded to my discretion. Resp. at 2–3. Petitioner did not file a reply. For the reasons set forth below, I hereby GRANT IN PART Petitioner’s motion, awarding fees and costs in the total amount of $55,439.35. I. Reasonable Basis is Met Although the Vaccine Act only guarantees a fees award to successful petitioners, a special master may also award fees and costs in an unsuccessful case if: (1) the “petition was brought in good faith”; and (2) “there was a reasonable basis for the claim for which the petition was brought.” Section 15(e)(1). I have in prior decisions set forth at length the criteria to be applied when determining if a claim possessed “reasonable basis” sufficient for a fees award. See, e.g., Sterling v. Sec’y of Health & Hum. Servs., No. 16-551V, 2020 WL 549443, at *4 (Fed. Cl. Spec. Mstr. Jan. 3, 2020). Importantly, establishing reasonable basis does not automatically entitle an unsuccessful claimant to fees, but is instead a threshold obligation; fees can still thereafter be limited, if unreasonable, or even denied entirely. A claim’s reasonable basis must be demonstrated through some objective evidentiary showing. Cottingham v. Sec’y of Health & Hum. Servs., 971 F.3d 1337, 1344 (Fed. Cir. 2020) (citing Simmons v. Sec’y of Health & Hum. Servs., 875 F.3d 632, 635 (Fed. Cir. 2017)). This objective inquiry is focused on the claim—counsel’s conduct is irrelevant (although it may bulwark good faith). Simmons, 875 F.3d at 635. In addition, reasonable basis inquiries are not static—they evaluate not only what was known at the time the petition was filed, but also take into account what is learned about the evidentiary support for the claim as the matter progresses. Perreira v. Sec’y of Health & Hum. Servs., 33 F.3d 1375, 1377 (Fed. Cir. 1994) (upholding the finding that a reasonable basis for petitioners’ claims ceased to exist once they had reviewed their expert's opinion, which consisted entirely of unsupported speculation). As a result, a claim can “lose” reasonable basis over time. The standard for finding the existence of reasonable basis is lesser (and, thus, inherently easier to satisfy) than the preponderant standard applied when assessing entitlement, as cases that fail can still have sufficient objective grounding for a fees award. Braun v. Sec’y of Health & Hum. Servs., 144 Fed. Cl. 72, 77 (2019). The Court of Federal Claims has affirmed that “[r]easonable basis is a standard that petitioners, at least generally, meet by submitting evidence.” Chuisano v. Sec’y of Health & Hum. Servs., 116 Fed. Cl. 276, 287 (Fed. Cl. 2014) (internal quotations omitted) (affirming special master). The factual basis and medical support for the claim is among the evidence that should be considered. Carter v. Sec’y of Health & Hum. Servs., 132 Fed. Cl. 372, 378 (Fed. Cl. 2017). Under the Vaccine Act, special masters have “maximum discretion” in applying the reasonable basis standard. See, e.g., Silva v. Sec’y of Health & Hum. Servs., 108 Fed. Cl. 401, 401–02 (Fed. Cl. 2012). Here, I find that the present claim possessed reasonable basis at its onset and through the date Petitioner requested its dismissal. The record confirms that Petitioner received a flu vaccine, and presented to medical professionals three weeks later with complaints of numbness. It appeared later in the case that Petitioner’s treatment developments would not support her claim of post- vaccination transverse myelitis, however. Petitioner chose to dismiss her case after it came to light that Petitioner would likely not be able to substantiate her claim (as reflected in her difficulty obtaining an expert). Thus, the claim possessed reasonable basis at least through the time of its dismissal. And there is no reason otherwise to deny a fees award. II. Calculation of Fees Determining the appropriate amount of a fees award is a two-part process. The first part involves application of the lodestar method—“multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Avera v. Sec’y of Health & Hum. Servs., 515 F.3d 1343, 1347–48 (Fed. Cir. 2008) (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). The second part involves adjusting the lodestar calculation up or down to take relevant factors into consideration. Id. at 1348. This standard for calculating a fee award is considered applicable in most cases where a fee award is authorized by federal statute. Hensley v. Eckerhart, 461 U.S. 424, 429–37 (1983). An attorney’s reasonable hourly rate is determined by the “forum rule,” which bases the proper hourly rate to be awarded on the forum in which the relevant court sits (Washington, D.C., for Vaccine Act cases), except where an attorney’s work was not performed in the forum and there is a substantial difference in rates (the so-called “Davis” exception”). Avera, 515 F.3d at 1348 (citing Davis Cty. Solid Waste Mgmt. & Energy Recovery Special Serv. Dist. v. U.S. Envtl. Prot. Agency, 169 F.3d 755, 758 (D.C. Cir. 1999)). A 2015 decision established the hourly rate ranges for attorneys with different levels of experience who are entitled to the forum rate in the Vaccine Program. See McCulloch v. Sec’y of Health & Hum. Servs., No. 09-293V, 2015 WL 5634323, at *19 (Fed. Cl. Spec. Mstr. Sept. 1, 2015). Petitioner requests the following rates for her attorneys and support staff, based on the years work was performed: 2021 2022 2023 2024 2025 Christina $380.00 $425.00 $470.00 $500.00 $537.00 Ciampolilo (Attorney) Patrick Kelly -- $250.00 -- $345.00 -- (Attorney) Ronald -- $475.00 $500.00 $525.00 $567.00 Homer (Attorney) Joseph Pepper -- -- -- $485.00 $516.00 (Attorney) Nathaniel Enos -- -- -- $360.00 $390.00 (Attorney) Meredith -- -- -- -- $516.00 Daniels (Attorney) Law Clerks -- -- -- $200.00 -- Paralegals $155.00 $170.00 $185.00 $195.00 $207.00 The attorneys at Conway, Homer, P.C. practice in Boston, MA—a jurisdiction that has been deemed “in forum.” Accordingly, they should be paid at forum rates, as established in McCulloch. See Lozano v. Sec’y of Health & Hum. Servs., No. 15-396V, 2020 WL 7869439, at *3 (Fed. Cl. Spec. Mstr. Nov. 30, 2020). The rates requested (including newly 2025 rates) are also consistent with what has previously been awarded for the work of these attorneys, in accordance with the Office of Special Masters’ fee schedule. 3 Vanore v. Sec’y of Health & Hum. Servs., No. 21-870V, 2025 WL 407022 (Fed. Cl. Spec. Mstr. Jan. 3, 2025). I thus find no cause to reduce them in this instance. And I find the time devoted to the case reasonable as well, and will not adjust the hours spent on this matter. III. Calculation of Attorney’s Costs Just as they are required to establish the reasonableness of requested fees, petitioners must also demonstrate that requested litigation costs are reasonable. Presault v. United States, 52 Fed. Cl. 667, 670 (2002). Reasonable costs include the costs of obtaining medical records and expert time incurred while working on a case. Fester v. Sec’y of Health & Hum. Servs., No.10-243V, 2013 WL 5367670, at *16 (Fed. Cl. Spec. Mstr. Aug. 27, 2013). When petitioners fail to substantiate a cost item, such as by not providing appropriate documentation to explain the basis for a particular cost, special masters have refrained from paying the cost at issue. See, e.g., Gardner-Cook v. Sec’y of Health & Hum. Servs., No. 99-480V, 2005 WL 6122520, at *4 (Fed. Cl. Spec. Mstr. June 30, 2005). 3 OSM Attorneys’ Forum Hourly Rate Fee Schedule, https://www.uscfc.uscourts.gov/osm-attorneys-forum-hourly- rate-fee-schedules (last visited Dec. 19, 2025). Petitioner seeks $1,877.29 in outstanding costs, including the filing fee, medical record retrieval costs, and mailing costs. Mot. at 25. However, documentation was only provided to substantiate $1,836.75 of that sum, which includes the Court's filing fee, medical records requests, copying expenses, and some mailing expenses. Id. at 27–40. I will only grant fees that are substantiated by documentation. Therefore, I grant $1,836.75 in attorney’s costs. CONCLUSION Based on the foregoing, and in the exercise of the discretion afforded to me in determining the propriety of a final fees award, I GRANT IN PART Petitioner’s Motion for Attorney’s Fees and Costs, awarding a total amount of $55,439.35, reflecting $53,602.60 in attorney’s fees and $1,836.75 in costs, to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court SHALL ENTER JUDGMENT in accordance with the terms of this Decision. 4 IT IS SO ORDERED. /s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master 4 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment if (jointly or separately) they file notices renouncing their right to seek review.